Michel Friesenhahn - Concepedia

Author

Michel Friesenhahn

Bayer (United States)

Also Known As

Christina Rabe, M FRIESENHAHN, M. Friesenhahn, Michel Friesenhahn, Michel J. Friesenhahn

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Bayer (United States)Cleveland Clinic Lou Ruvo Brain Institute Gene Therapy Laboratory BC Centre for Disease Control

About

Michel Friesenhahn is an author at Bayer (United States) specializing in medicine, neurology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	238
2	Health Sciences	1	1	79
3	Natural Sciences	1	1	46
4	Hepatology	1	1	20
5	Immunology	1	1	28

Michel Friesenhahn

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A Binding Properties Promotes Neuroprotection and Glial Engulfment of A Oskar Adolfsson, Maria Pihlgren, Nicolas Toni, Journal of Neuroscience	2012	296
ABBY Jeffrey L. Cummings, Sharon Cohen, Christopher H. van Dyck, Neurology	2018	247
Quantifying Antivascular Effects of Monoclonal Antibodies to Vascular Endothelial Growth Factor: Insights from Imaging James P.B. O’Connor, Richard A.D. Carano, Andrew R. Clamp, Clinical Cancer Research	2009	158
Amyloid positron emission tomography and cerebrospinal fluid results from a crenezumab anti-amyloid-beta antibody double-blind, placebo-controlled, randomized phase II study in mild-to-moderate Alzheimer’s disease (BLAZE) Stephen Salloway, Lee Honigberg, Michael E. Ward, Alzheimer s Research & Therapy	2018	149
Clinical performance and robustness evaluation of plasma amyloid‐β<sub>42/40</sub> prescreening Christina Rabe, Tobias Bittner, Alexander Jethwa, Alzheimer s & Dementia Geriatric PsychiatryNeurodegenerative DiseasesAlzheimer's DiseaseTreatment EvaluationPlasma Aβ 42	2022	79
A PHASE IA DOSE-ESCALATION STUDY OF THE ANTI-FACTOR D MONOCLONAL ANTIBODY FRAGMENT FCFD4514S IN PATIENTS WITH GEOGRAPHIC ATROPHY V. Diana, Dante J. Pieramici, Menno van Lookeren Campagne, Retina	2013	51
An Unusual Mode of DNA Duplex Association: Watson-Crick Interaction of All-Purine Deoxyribonucleic Acids Thomas R. Battersby, Maria Albalos, Michel Friesenhahn Chemistry & Biology ChromatinDna SequencingDnaMedicineGenetics	2007	46
Safety, Tolerability, and Pharmacokinetics of GDC-0276, a Novel NaV1.7 Inhibitor, in a First-in-Human, Single- and Multiple-Dose Study in Healthy Volunteers Michael E. Rothenberg, Michael Tagen, Jae H. Chang, Clinical Drug Investigation Molecular PharmacologyMedicineHealthy VolunteersMultiple-dose StudyClinical Pharmacology	2019	44
Multicenter Evaluation of the VERSANT HCV RNA Qualitative Assay for Detection of Hepatitis C Virus RNA David A. Hendricks, Michel Friesenhahn, Lorine Tanimoto, Journal of Clinical Microbiology	2003	42
Performance Evaluation of the VERSANT HCV RNA Qualitative Assay by Using Transcription-Mediated Amplification G. Gorrin, Michel Friesenhahn, Patsy Lin, Journal of Clinical Microbiology	2003	40

Page 1